CHRISTIANA CARE HEALTH SERVICES INC has a total of 14 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are SYNPROMICS LTD, OASIS BIOSCIENCES INC and MARROW TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Therapeutic chemical compounds | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Tarcic Gabi | 6 |
#2 | Vidne Michael | 6 |
#3 | Kmiec Eric | 5 |
#4 | Kmiec Eric Brian | 4 |
#5 | Bialk Pawel | 4 |
#6 | Sims-Mourtada Jennifer | 2 |
#7 | Kmiec Eric B | 2 |
#8 | Atallah Chalita | 1 |
#9 | Marsh Adam | 1 |
#10 | Marsh Adam G | 1 |
Publication | Filing date | Title |
---|---|---|
US2021121133A1 | System and method for risk detection and intervention to prevent sudden death | |
US2020370041A1 | Gene knockout of variant nrf2 for treatment of cancer | |
US2020370047A1 | Gene knockout of nrf2 for treatment of cancer | |
WO2019055505A1 | Identification of epigenetic signatures indicating breast cancer | |
CA3048501A1 | Methods for in vitro site-directed mutagenesis using gene editing technologies | |
US2017198277A1 | Compositions and Methods for Improving Homogeneity of DNA Generated Using a CRISPR/Cas9 Cleavage System |